Topic: Adult

Journal: British Journal of Cancer

Documents

A list of abstracts that contain a topic of "Adult" and a journal name of "British Journal of Cancer".

• Molar Pregnancy and Childhood Cancer: a Population-based Linkage Study from Denmark.

  PMID: 17700569

• High Expression of Rela/P65 is Associated with Activation of Nuclear Factor-kappab-dependent Signaling in Pancreatic Cancer and Marks a Patient Population with Poor Prognosis.

  PMID: 17622249

• Public Awareness That Hpv is a Risk Factor for Cervical Cancer.

  PMID: 17687335

• Raltitrexed-eloxatin Salvage Chemotherapy in Gemcitabine-resistant Metastatic Pancreatic Cancer.

  PMID: 16508631

• Metallothionein - Overexpression As a Highly Significant Prognostic Factor in Melanoma: a Prospective Study on 1270 Patients.

  PMID: 16508630

• Expression of Ppardelta in Multistage Carcinogenesis of the Colorectum: Implications of Malignant Cancer Morphology.

  PMID: 16969348

• Phase-i Trial of Oral Fluoropyrimidine Anticancer Agent (S-1) with Concurrent Radiotherapy in Patients with Unresectable Pancreatic Cancer.

  PMID: 17437021

• A Single Institutional Experience of Thymic Epithelial Tumours over 11 Years: Clinical Features and Outcome and Implications for Future Management.

  PMID: 17592498

• Autoantibodies to Endostatin in Patients with Breast Cancer: Correlation to Endostatin Levels and Clinical Outcome.

  PMID: 16552441

• Second Primary Cancer in Survivors Following Concurrent Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.

  PMID: 17031394

• Telomerase Peptide Vaccination of Patients with Non-resectable Pancreatic Cancer: A Dose Escalating Phase I/Ii Study.

  PMID: 17060934

• Phase I/Ii Study of S-1 Combined with Paclitaxel in Patients with Unresectable And/Or Recurrent Advanced Gastric Cancer.

  PMID: 17133268

• Dna Repair Capacity As a Possible Biomarker of Breast Cancer Risk in Female Brca1 Mutation Carriers.

  PMID: 17213827

• First-into-man Phase I and Pharmacokinetic Study of Xr5944.14, a Novel Agent with a Unique Mechanism of Action.

  PMID: 17848959

• A Phase Ii Study of Single-agent Gefitinib As First-line Therapy in Patients with Stage Iv Non-small-cell Lung Cancer.

  PMID: 16670714

• Cancer Risk Among Users of Neuroleptic Medication: a Population-based Cohort Study.

  PMID: 16926836

• Emotional Distress in Cancer Patients: the Edinburgh Cancer Centre Symptom Study.

  PMID: 17311020

• Adjuvant Imatinib Treatment Improves Recurrence-free Survival in Patients with High-risk Gastrointestinal Stromal Tumours (Gist).

  PMID: 17533389

• Mortality in Women Given Diethylstilbestrol During Pregnancy.

  PMID: 16786044

• Insulin-like Growth Factors and Cancer: No Role in Screening. Evidence from the Bupa Study and Meta-analysis of Prospective Epidemiological Studies.

  PMID: 16804529

• Novel Heteroduplex Method Using Small Cytology Specimens with a Remarkably High Success Rate for Analysing Egfr Gene Mutations with a Significant Correlation to Gefitinib Efficacy in Non-small-cell Lung Cancer.

  PMID: 17047654

• Optimal Indications of Endocrine Therapy Alone As Adjuvant Systemic Treatment of Breast Cancer.

  PMID: 17726451

• Benefit from Preoperative Radiotherapy in Rectal Cancer Treatment: Disease-free Patients' and Oncologists' Preferences.

  PMID: 17848910

• Palliative Chemotherapy Beyond Three Courses Conveys No Survival or Consistent Quality-of-life Benefits in Advanced Non-small-cell Lung Cancer.

  PMID: 17047644

• Neoadjuvant Chemotherapy in Breast Cancer: Early Response Prediction with Quantitative Mr Imaging and Spectroscopy.

  PMID: 16465174

• Mitomycin C and Vinorelbine for Second-line Chemotherapy in Nsclc--a Phase Ii Trial.

  PMID: 17353918

• Mortality and Incidence of Second Cancers Following Treatment for Testicular Cancer.

  PMID: 17262080

---